These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 10916808

  • 1. [Antisecretory drugs and prophylaxis of secondary gastrointestinal effects associated with the consumption of non steroid anti-inflammatory drugs].
    Lanas A, Arroyo MT.
    Med Clin (Barc); 2000; 114 Suppl 2():57-62. PubMed ID: 10916808
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S, Ittel TH, Wietholtz H.
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [Abstract] [Full Text] [Related]

  • 4. Prevention of NSAID-gastropathy.
    Ardizzone S, Bianchi Porro G.
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [Abstract] [Full Text] [Related]

  • 5. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.
    Agrawal NM, Dajani EZ.
    J Assoc Acad Minor Phys; 1992 Dec; 3(4):142-8. PubMed ID: 1392409
    [Abstract] [Full Text] [Related]

  • 6. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1091-7. PubMed ID: 15569111
    [Abstract] [Full Text] [Related]

  • 7. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY.
    Am J Med; 2001 Jan 08; 110(1A):58S-61S. PubMed ID: 11166000
    [Abstract] [Full Text] [Related]

  • 8. [Treatment and prevention of gastrointestinal complications caused by non-steroidal antiphlogistic agents].
    Rybár I, Kriska M, Vavrecka A, Hyrdel R, Rovenský J.
    Cas Lek Cesk; 1999 Nov 15; 138(22):675-80. PubMed ID: 10746025
    [Abstract] [Full Text] [Related]

  • 9. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 15; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 10. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.
    Hirschowitz BI.
    Gastroenterologist; 1994 Sep 15; 2(3):207-23. PubMed ID: 7987619
    [Abstract] [Full Text] [Related]

  • 11. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M, Dezi A, Ferrario F, Capurso I.
    Arch Intern Med; 1996 Nov 11; 156(20):2321-32. PubMed ID: 8911239
    [Abstract] [Full Text] [Related]

  • 12. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A, García-Rodríguez LA, Arroyo MT, Bujanda L, Gomollón F, Forné M, Aleman S, Nicolas D, Feu F, González-Pérez A, Borda A, Castro M, Poveda MJ, Arenas J, Investigators of the Asociación Española de Gastroenterología (AEG).
    Am J Gastroenterol; 2007 Mar 11; 102(3):507-15. PubMed ID: 17338735
    [Abstract] [Full Text] [Related]

  • 13. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG.
    Am J Gastroenterol; 1996 Feb 11; 91(2):223-7. PubMed ID: 8607484
    [Abstract] [Full Text] [Related]

  • 14. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.
    J Rheumatol; 2002 Mar 11; 29(3):467-73. PubMed ID: 11908558
    [Abstract] [Full Text] [Related]

  • 15. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 11; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 16. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
    Wilcox CM, Shalek KA, Cotsonis G.
    Arch Intern Med; 1994 Jan 10; 154(1):42-6. PubMed ID: 8267488
    [Abstract] [Full Text] [Related]

  • 17. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C, Pelosini I.
    Ital J Gastroenterol Hepatol; 1999 Jan 10; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [Abstract] [Full Text] [Related]

  • 18. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM, Bytzer P.
    Ugeskr Laeger; 2001 Oct 29; 163(44):6103-5. PubMed ID: 11715151
    [Abstract] [Full Text] [Related]

  • 19. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
    Rostom A, Wells G, Tugwell P, Welch V, Dubé C, McGowan J.
    J Rheumatol; 2000 Sep 29; 27(9):2203-14. PubMed ID: 10990235
    [Abstract] [Full Text] [Related]

  • 20. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS, Beglinger C.
    Schweiz Med Wochenschr; 1999 Jul 27; 129(29-30):1073-80. PubMed ID: 10464910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.